Guidance for stem cell therapy for juvenile systemic sclerosis patients
Introduction: Hemopoetic stem cell transplantation (HSTC) and cellular therapies (CT) are a promising therapeutic options for adult and for juvenile systemic sclerosis (jSSc) patients. Currently, studies regarding efficacy of this procedure are derived mostly from adult patients. As pediatric patients [for full text, please go to the a.m. URL]
Institutions
- Semmelweis University (HU)
- Hackensack University Medical Center (US)
- University of Lisbon (PT)
- Royal Free London NHS Foundation Trust (GB)
- Great Ormond Street Hospital (GB)
- House of Representatives (NL)
- Ghent University Hospital (BE)
- Martin University (US)
- Fundación de Estudios Superiores Comfanorte (CO)
- Alder Hey Children's NHS Foundation Trust (GB)
- Children's Hospital Colorado (US)
- Children's Hospital of Pittsburgh (US)
- Hamburg Institut (Germany) (DE)
- Ospedale Policlinico San Martino (IT)
- University Hospital Cologne (DE)
- Asklepios Kliniken Hamburg (DE)
- University College London (GB)
- University of Tübingen (DE)
- University of Colorado Denver (US)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-09-18
- DOI
- https://doi.org/10.3205/24dgrh126
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00